SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $20,600 | +18.4% | 1,001 | +170.5% | 0.00% | – |
Q2 2023 | $17,397 | +14.2% | 370 | +1.9% | 0.00% | – |
Q1 2023 | $15,232 | +10.0% | 363 | 0.0% | 0.00% | – |
Q4 2022 | $13,846 | -1.1% | 363 | 0.0% | 0.00% | – |
Q3 2022 | $14,000 | +16.7% | 363 | -4.0% | 0.00% | – |
Q2 2022 | $12,000 | -45.5% | 378 | -45.1% | 0.00% | – |
Q1 2022 | $22,000 | -38.9% | 688 | -17.8% | 0.00% | – |
Q4 2021 | $36,000 | +5.9% | 837 | +11.6% | 0.00% | – |
Q3 2021 | $34,000 | -44.3% | 750 | -29.1% | 0.00% | – |
Q2 2021 | $61,000 | -23.8% | 1,058 | -1.0% | 0.00% | – |
Q1 2021 | $80,000 | +8.1% | 1,069 | +24.6% | 0.00% | – |
Q4 2020 | $74,000 | +48.0% | 858 | +6.1% | 0.00% | – |
Q3 2020 | $50,000 | +56.2% | 809 | +7.6% | 0.00% | – |
Q2 2020 | $32,000 | +52.4% | 752 | +0.3% | 0.00% | – |
Q1 2020 | $21,000 | -12.5% | 750 | +123.9% | 0.00% | – |
Q4 2019 | $24,000 | -75.5% | 335 | -51.9% | 0.00% | – |
Q3 2019 | $98,000 | +25.6% | 696 | +61.9% | 0.00% | – |
Q2 2019 | $78,000 | -11.4% | 430 | -21.1% | 0.00% | – |
Q1 2019 | $88,000 | +1660.0% | 545 | +1138.6% | 0.00% | – |
Q4 2018 | $5,000 | -44.4% | 44 | -30.2% | 0.00% | – |
Q3 2018 | $9,000 | +50.0% | 63 | +65.8% | 0.00% | – |
Q2 2018 | $6,000 | +50.0% | 38 | +58.3% | 0.00% | – |
Q1 2018 | $4,000 | +100.0% | 24 | +140.0% | 0.00% | – |
Q4 2017 | $2,000 | 0.0% | 10 | -86.7% | 0.00% | – |
Q2 2016 | $2,000 | -33.3% | 75 | -3.8% | 0.00% | – |
Q1 2016 | $3,000 | -72.7% | 78 | -58.7% | 0.00% | – |
Q4 2015 | $11,000 | +57.1% | 189 | +5.0% | 0.00% | – |
Q3 2015 | $7,000 | -56.2% | 180 | -19.3% | 0.00% | – |
Q2 2015 | $16,000 | +77.8% | 223 | +31.2% | 0.00% | – |
Q1 2015 | $9,000 | – | 170 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |